Drreddys Laboratories | RDY - Assets


Drreddys Laboratories reported INR579.35B in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
ANI Pharmaceuticals USD 1.49B 72.14M Jun/2026
Aurora Cannabis CAD 601.09M 174.2M Mar/2026
Bayer EUR 107.29B 659M Jun/2026
Canopy Growth CAD 1.12B 12.54M Mar/2026
Cipla INR 434.34B 9.38B Sep/2026
Corcept Therapeutics USD 888.7M 73.82M Jun/2026
Drreddys Laboratories INR 579.35B 573.08B Mar/2026
GlaxoSmithKline GBP 71.7B 9.96B Sep/2026
Hikma Pharmaceutical USD 5.67B 117M Dec/2025
Lonza CHF 18.97B 164M Dec/2025
Novartis USD 122.03B 3.5B Jun/2026
Pacira USD 1.24B 35.44M Jun/2026
Phibro Animal Health USD 1.5B 56.12M Jun/2026
Prestige Brands USD 4.57B 1.07B Jun/2026
Richter Gedeon HUF 1.76T 79.96B Mar/2026
Sun Pharmaceuticals INR 1.09T 50.79B Mar/2026
Supernus Pharmaceuticals USD 1.4B 30.42M Sep/2026
Teva Pharmaceutical Industries USD 39.86B 183M Jun/2026